About
Ian W. Mills is an Entrepreneur-in-Residence at Frazier Life Sciences, having joined in March 2020, with a background as a pharmaceutical development executive. He previously served as Chief Medical Officer at Outpost Medicine and Head of Clinical Development at Mitsubishi Tanabe Pharma Europe, and spent over 15 years at Pfizer in clinical and development leadership roles. He holds an MA in Natural Sciences from Cambridge University and a medical degree and medical doctorate from Oxford University.
Invests in
Biotech
Experience
- Sudo BiosciencesChief Medical Officercurrent2021 β present
- Mills Medical LtdConsultant Pharmaceutical Physiciancurrent2020 β present
- Frazier Healthcare PartnersEntrepreneur in Residencecurrent2020 β present
- Pioneer TherapeuticsChief Medical Officer2020 β 2021
- Outpost MedicineChief Medical Officer2017 β 2020London Area, United Kingdom
- Mitsubishi Tanabe Pharma Europe LtdHead of Clinical Development2017London Area, United Kingdom
- PfizerVice President, Global Clinical Head2014 β 2016Tadworth, UK
- PfizerVice President, Head Regional Medical Monitors2011 β 2016Tadworth, UK
- PfizerVice President, Clinical Group Head2008 β 2011Sandwich, UK
- PfizerTherapeutic Area Clinical Lead, Development Team Lead2005 β 2008Sandwich, UK
- PfizerClinician, Clinical Lead2001 β 2005Sandwich, UK
- NHSMedical Doctor1991 β 2001
Education
- University of OxfordDM, Medical Research / Pharmacology1996 β 1999
- University of OxfordBM, BCh1988 β 1991
- University of CambridgeMA, Natural Sciences (Experimental Psychology)1985 β 1988
- Downside School1979 β 1984
Skills & more
Clinical Trials22Clinical Research12Clinical Development27Drug Development13GCP6Medical Affairs3Oncology3Regulatory Affairs1Regulatory Submissions2CRO Management1Life Sciences2Good Clinical Practice (GCP)1
+5 more
Therapeutic AreasDrug DiscoveryBiotechnologyCROPharmaceutical IndustryFrom Ian's professional profile.
Same school
Also attended University of Oxford688
Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageBrad GerstnerFounder & CEO of Altimeter CapitalDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index VenturesJan HammerInvestor at Index Ventures
+ 682 more
Also attended University of Cambridge621
Niko BonatsosInvestment Team at General CatalystGeorgia StevensonInvestor at Index VenturesHannah SealInvestor at Index VenturesAnthony PhilippakisInvestor at GV (Google Ventures)Erik NordlanderInvestor at GV (Google Ventures)Nic LowdenInvestor at Moonfire Ventures
+ 615 more
Also attended Downside School9
Fernando DΓaz SolΓsCo-founder and Managing Partner at Kibo VenturesDavid DennyManaging Partner and Co-Founder at Longwall Venture Partners LLPJames Scott-GattyNon-Executive Director at OakglenBella TaylerTrainee Investment Manager - UK at OakglenStephen GeddesInvestor at Two MagnoliasClare HunterHead of Brand, Communications and Marketing at Backed
+ 3 more
Shared employers
Also worked at Sudo Biosciences3
Also worked at Pfizer118
Jigar RaythathaInvestor at Third Rock VenturesAbbie CelnikerInvestor at Third Rock VenturesErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesRichard ChesworthInvestor at Third Rock VenturesJohn McKearnSenior Advisor at RiverVest Venture Partners, focused on early-stage biotech
+ 112 more
Colleagues at Frazier Life Sciences
Adam Simpson
Venture Partner at Frazier Life Sciences
Aditya Kohli
Partner at Frazier Life Sciences
Alan Frazier
Chairman Emeritus at Frazier Life Sciences
Albert Cha
Managing Partner at Frazier Life Sciences
Ali Jackson
Vice President and Counsel, Public Funds at Frazier Life Sciences
Amanda Wilson
Senior Tax Manager at Frazier Life Sciences
Angel Martin
Senior Associate at Frazier Life Sciences
Angie You
Senior Advisor at Frazier Life Sciences




.png)






























